Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 1
2001 1
2003 1
2005 1
2006 1
2008 2
2009 5
2010 4
2011 2
2012 2
2013 1
2014 1
2015 3
2016 2
2017 2
2019 1
2020 4
2021 7
2022 4
2023 1
2024 5
2025 6
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial.
Ludvigsson J, Sumnik Z, Pelikanova T, Nattero Chavez L, Lundberg E, Rica I, Martínez-Brocca MA, Ruiz de Adana M, Wahlberg J, Katsarou A, Hanas R, Hernandez C, Clemente León M, Gómez-Gila A, Lind M, Lozano MF, Sas T, Samuelsson U, Pruhova S, Dietrich F, Puente Marin S, Nordlund A, Hannelius U, Casas R. Ludvigsson J, et al. Diabetes Care. 2021 Jul;44(7):1604-1612. doi: 10.2337/dc21-0318. Epub 2021 May 21. Diabetes Care. 2021. PMID: 34021020 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate the efficacy of aluminum-formulated intralymphatic glutamic acid decarboxylase (GAD-alum) therapy combined with vitamin D supplementation in preserving endogenous insulin secretion in all patients with type 1 diabetes (T1D) or in a gene …
OBJECTIVE: To evaluate the efficacy of aluminum-formulated intralymphatic glutamic acid decarboxylase (GAD-alum) therapy combi …
Effectiveness of amino acid supplementation in preventing acute kidney injury following cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.
Majeed MW, Finnegan E, Gallo Ruelas M, Lopes LM, Righetto BB, Salha I, Delgado D, Quirós MC, Tomo ATJ, Ahmad R, Andrabi S, Abujaber S. Majeed MW, et al. Acta Anaesthesiol Scand. 2025 Jul;69(6):e70037. doi: 10.1111/aas.70037. Acta Anaesthesiol Scand. 2025. PMID: 40411139
AA mixture interventions significantly reduced the risk of AKI stage 1 (RR: 0.56; 95% CI: 0.77-0.96; p = .009; CoE: Moderate) and Stage 3 (RR: 0.53; 95% CI: 0.34-0.83; p = .005; CoE: Moderate), but not stage 2 (RR: 1.24; 95% CI: 0.60-2.55; p = .568; CoE: Low). Preliminary finding …
AA mixture interventions significantly reduced the risk of AKI stage 1 (RR: 0.56; 95% CI: 0.77-0.96; p = .009; CoE: Moderate) and Stage 3 (R …
A randomised controlled trial of the effects of Galacto-Oligosaccharides on the gut brain-axis of young females.
Johnstone N, Cohen Kadosh K. Johnstone N, et al. Brain Behav Immun. 2025 Oct;129:573-584. doi: 10.1016/j.bbi.2025.06.020. Epub 2025 Jun 16. Brain Behav Immun. 2025. PMID: 40532960 Clinical Trial.
Assessments occurred at baseline, endline, and 28 days post-supplementation. The primary outcome was trait anxiety, secondary outcomes were brain-based levels of GABA and glutamate in the dorsolateral prefrontal cortex (dlPFC), anterior cingulate cortex, and inferior occip …
Assessments occurred at baseline, endline, and 28 days post-supplementation. The primary outcome was trait anxiety, secondary outcome …
Effect of l-glutamic acid supplementation on performance and nitrogen balance of broilers fed low protein diets.
Bezerra RM, Costa FG, Givisiez PE, Freitas ER, Goulart CC, Santos RA, Souza JG, Brandão PA, Lima MR, Melo ML, Rodrigues VP, Nogueira ET, Vieira DV. Bezerra RM, et al. J Anim Physiol Anim Nutr (Berl). 2016 Jun;100(3):590-600. doi: 10.1111/jpn.12405. Epub 2015 Nov 28. J Anim Physiol Anim Nutr (Berl). 2016. PMID: 26614118 Clinical Trial.
The aim of this study was to evaluate the effect of protein reduction and supplementation of l-glutamic acid in male broiler diets. A total of 648 chicks of the Cobb 500 strain were distributed in a completely randomized design with six treatments and six rep …
The aim of this study was to evaluate the effect of protein reduction and supplementation of l-glutamic acid in male br …
The Effects of Curcumin on the Side Effects of Anticancer Drugs in Chemotherapy: A Randomized Controlled Trial.
Panahi Y, Vahedian-Azimi A, Saadat A, Togeh G, Rahimibashar F, Fetrat MK, Amirfakhrian H, Moallem SA, Majeed M, Sahebkar A. Panahi Y, et al. Adv Exp Med Biol. 2021;1328:255-273. doi: 10.1007/978-3-030-73234-9_17. Adv Exp Med Biol. 2021. PMID: 34981483 Clinical Trial.
The prophylactic effect of curcumin against chemotherapy-induced damage and side effects was evaluated in a double-blind, placebo-controlled randomized trial. Eighty cancer patients on standard chemotherapy regimens were randomly assigned to receive curcumin …
The prophylactic effect of curcumin against chemotherapy-induced damage and side effects was evaluated in a double-blind, placebo-control …
Influence of Dietary Supplementation for Hyperhomocysteinemia Treatments.
Vezzoli A, Dellanoce C, Caimi TM, Vietti D, Montorsi M, Mrakic-Sposta S, Accinni R. Vezzoli A, et al. Nutrients. 2020 Jun 30;12(7):1957. doi: 10.3390/nu12071957. Nutrients. 2020. PMID: 32630031 Free PMC article. Clinical Trial.
Hyperhomocysteinemia is recognized as risk factor for cardiovascular and age-associated diseases. Folic acid supplementation efficiently lowers plasma homocysteine (Hcy) levels, but high intake may negatively affect health because of unnatural levels of unmetabolize …
Hyperhomocysteinemia is recognized as risk factor for cardiovascular and age-associated diseases. Folic acid supplementation e …
Aesthetic Radiofrequency Associated with Rosmarinus officinalis Supplementation is Safe and Reduces Oxidative Stress in Women: Randomized, and Double-Blind Clinical Trial.
Tremêa GTF, Kleibert KRU, Krause LS, Fell APW, Scapini AR, Marschall KW, Baiotto CS, da Silva MHT, da Silva JAG, Colet CF. Tremêa GTF, et al. J Evid Based Integr Med. 2024 Jan-Dec;29:2515690X241246293. doi: 10.1177/2515690X241246293. J Evid Based Integr Med. 2024. PMID: 39135397 Free PMC article. Clinical Trial.
The objective were to evaluate the effects of supplementation of standardized dry extract of Rosmarinus officinalis (RO) and the application of aesthetic radiofrequency on the oxidative stress markers catalase (CAT), superoxide dismutase (SOD), non-protein thiols (NP-SH), …
The objective were to evaluate the effects of supplementation of standardized dry extract of Rosmarinus officinalis (RO) and the appl …
Efficacy and safety of integrative therapy of Drakshavaleha with oral iron folic acid supplements in management of mild to moderate iron deficiency anaemia in women of reproductive age group- A protocol for a parallel group randomized controlled trial.
Barvaliya MJ, Karun KM, Chandrashekar MS, Chandan N, Hegde HV, Sagare SS, Bs R, Roy S. Barvaliya MJ, et al. J Ayurveda Integr Med. 2026 May-Jun;17(3):101352. doi: 10.1016/j.jaim.2026.101352. Epub 2026 May 22. J Ayurveda Integr Med. 2026. PMID: 42172814 Free PMC article.
This paper presents a protocol for the randomized controlled trial (RCT) assessing the efficacy and safety of integrating Drakshavaleha with IFA supplementation in improving hemoglobin levels among women aged 18-49 years with mild to moderate iron-defi …
This paper presents a protocol for the randomized controlled trial (RCT) assessing the efficacy and safety of integrati …
Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol.
Ziegler AG, Arnolds S, Kölln A, Achenbach P, Berner R, Bonifacio E, Casteels K, Elding Larsson H, Gündert M, Hasford J, Kordonouri O, Lundgren M, Oltarzewski M, Pekalski ML, Pfirrmann M, Snape MD, Szypowska A, Todd JA; GPPAD STUDY GROUP. Ziegler AG, et al. BMJ Open. 2021 Nov 9;11(11):e052449. doi: 10.1136/bmjopen-2021-052449. BMJ Open. 2021. PMID: 34753762 Free PMC article.
Secondary outcomes are (1) Any persistent confirmed beta-cell autoantibody, defined as at least one confirmed autoantibody in two consecutive samples, including insulin autoantibodies, glutamic acid decarboxylase, islet tyrosine phosphatase 2 or zinc transporter 8, …
Secondary outcomes are (1) Any persistent confirmed beta-cell autoantibody, defined as at least one confirmed autoantibody in two consecutiv …
Tolerance and safety evaluation of L-glutamic acid, N,N-diacetic acid as a feed additive in broiler diets.
Boerboom G, Martín-Tereso J, Veldkamp T, van Harn J, Bikker P, Busink R. Boerboom G, et al. Poult Sci. 2022 Feb;101(2):101623. doi: 10.1016/j.psj.2021.101623. Epub 2021 Nov 29. Poult Sci. 2022. PMID: 34936962 Free PMC article.
The novel chelator, L-glutamic acid, N,N-diacetic acid (GLDA) can be used as a dietary ingredient to safely reduce Zn supplementation in complete feed, without compromising the Zn status of farm animals. ...
The novel chelator, L-glutamic acid, N,N-diacetic acid (GLDA) can be used as a dietary ingredient to safely reduce Zn …
51 results